Botulism Immune Globulin Clinical Trials

• Study of Human Botulism Immunoglobulin in Infants With Botulism
  ClinicalTrials.gov Identifier: NCT00004401 - Recruiting
  Infant Botulism; Botulism
  
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
  ClinicalTrials.gov Identifier: NCT00000751 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Intravenous Pertussis Immune Globulin in Patients with Severe Childhood Pertussis Infection
  ClinicalTrials.gov Identifier: NCT00004422 - Active, not recruiting
  Pertussis; Whooping Cough
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
  Multiple Sclerosis
  
• Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy
  ClinicalTrials.gov Identifier: NCT00542997 - Recruiting
  Common Variable Immunodeficiency; X-Linked Agammaglobulinemia
  
• Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002809 - Active, not recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ...
  
• Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
  ClinicalTrials.gov Identifier: NCT00547365 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients with Subacute Proximal Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00004407 - Active, not recruiting
  Diabetic Neuropathies
  
• Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00017550 - Active, not recruiting
  Refractory Anemia; refractory anemia with excess blasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes
  
• Safety Study of an Intravenous Staphylococcus aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
  ClinicalTrials.gov Identifier: NCT00066989 - Completed
  Staphylococcal Infections
  
• Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
  ClinicalTrials.gov Identifier: NCT00031291 - Completed
  Anthrax
  
• Safety Study of Anthrax Immune Globulin Derived From Human Serum
  ClinicalTrials.gov Identifier: NCT00448253 - Recruiting
  Symptoms of Inhalational Anthrax
  
• Randomized Study of Intravenous Immunoglobulin in Patients with Mild or Moderate Myasthenia Gravis
  ClinicalTrials.gov Identifier: NCT00004682 - Active, not recruiting
  Myasthenia Gravis
  
• Efficacy of High-Dose Intravenous Immune Globulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
  ClinicalTrials.gov Identifier: NCT00288600 - Recruiting
  Hyperbilirubinemia; Erythroblastosis, Fetal
  
• Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004208 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00001999 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00157079 - Completed
  Primary Immunodeficiency Disorders; Immune Thrombocytopenic Purpura (ITP); Kawasaki syndrome
  
• Safety and Behavior of S. aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients with S. aureus Bacteremia and Continuing Fever
  ClinicalTrials.gov Identifier: NCT00063089 - Completed
  Staphylococcal Infections
  
• Development of Immune Globulin Treatment for Avian Flu
  ClinicalTrials.gov Identifier: NCT00383071 - Recruiting
  Infectious Diseases; Influenza; Avian Flu
  
• Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
  ClinicalTrials.gov Identifier: NCT00004286 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
  ClinicalTrials.gov Identifier: NCT00195637 - Active, not recruiting
  Hereditary Inclusion Body Myopathy
  
• Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00005937 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00473824 - Recruiting
  Hepatitis C Virus; Liver Transplantation
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00004772 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Treatment of Survivors After Botulism Outbreak
  ClinicalTrials.gov Identifier: NCT00314080 - Completed
  Respiratory Failure; Botulism
  
• A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
  ClinicalTrials.gov Identifier: NCT00000720 - Completed
  HIV Infections
  
• Botulism Outbreak in Thailand (Episode II)
  ClinicalTrials.gov Identifier: NCT00348426 - Completed
  Botulism
  
• IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00228852 - Recruiting
  T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
  
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004747 - Completed
  Cystic Fibrosis; Bacterial Infections
  
• Study of Immune Ablation With High-Dose Cyclophosphamide and Anti-Thymocyte Globulin Followed By Autologous Peripheral Blood Stem Cell Rescue in Patients With Severe Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00014703 - No longer recruiting
  Crohn's Disease
  
• Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects with Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00162006 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00016458 - Active, not recruiting
  Systemic Sclerosis
  
• Biological Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005853 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients with Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
  ClinicalTrials.gov Identifier: NCT00161993 - Completed
  Hypogammaglobulinemia; Agammaglobulinemia; Primary immunodeficiency (PID)
  
• Phase I Safety Study of anti-HIV Immune Serum Globulin (Human)
  ClinicalTrials.gov Identifier: NCT00002036 - Completed
  HIV Infections
  
• Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
  ClinicalTrials.gov Identifier: NCT00006630 - Terminated
  Healthy; Communicable Diseases
  
• Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00017641 - Active, not recruiting
  Systemic Lupus Erythematosus
  
• Phase III Randomized Study of Cyclophosphamide with or without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients with Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00004474 - Active, not recruiting
  Aplastic Anemia
  
• The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea
  ClinicalTrials.gov Identifier: NCT00002264 - Completed
  Cryptosporidiosis; HIV Infections
  
• Allogeneic Peripheral Stem Cell Transplantation After Antithymocyte Globulin, High-Dose Melphalan, and Fludarabine in Treating Women With Metastatic Adenocarcinoma of the Breast
  ClinicalTrials.gov Identifier: NCT00074269 - Recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Kidney Transplants in People with HIV Infection
  ClinicalTrials.gov Identifier: NCT00023478 - Active, not recruiting
  HIV Infections; End-Stage Renal Disease
  
• Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
  ClinicalTrials.gov Identifier: NCT00220727 - Completed
  Purpura, Thrombocytopenic
  
• Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00016419 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• Yellow Fever Virus Vaccine and Immune Globulin Study
  ClinicalTrials.gov Identifier: NCT00254826 - Recruiting
  Viremia; Yellow Fever Virus Vaccine
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00003913 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006379 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients with End-Stage Renal Disease Who are Highly Sensitized to Transplant Antigens
  ClinicalTrials.gov Identifier: NCT00000935 - Completed
  End-Stage Renal Disease; Kidney Transplantation
  
• Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00055653 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00068523 - Active, not recruiting
  chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Phase I Study of High-Dose Cyclophosphamide, Anti-Thymocyte Globulin, and Total Body Irradiation With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00017615 - Recruiting
  Rheumatoid Arthritis; Juvenile Rheumatoid Arthritis
  
• Total-Body Irradiation Plus Chemotherapy Followed By Donor Bone Marrow Transplantation in Treating Children With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00028730 - Active, not recruiting
  acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; chronic leukemia; ...
  
• Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
  ClinicalTrials.gov Identifier: NCT00010335 - Recruiting
  Systemic Sclerosis; Systemic Lupus Erythematosus; Dermatomyositis; Juvenile Rheumatoid Arthritis; Autoimmune Diseases
  
• Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00436761 - Active, not recruiting
  Unspecified Childhood Solid Tumor, Protocol Specific
  
• Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00301951 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00054340 - Active, not recruiting
  acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease
  
• Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003839 - Recruiting
  Cancer
  
• Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00217386 - Active, not recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00033293 - Recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
  ClinicalTrials.gov Identifier: NCT00084695 - Recruiting
  Fanconi's Anemia; Cancer
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003661 - Active, not recruiting
  Leukemia; Lymphoma
  
• Safety/Efficacy of Induction Agents with Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00113269 - Active, not recruiting
  Kidney Transplantation
  
• Combination Therapy of Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00001964 - Active, not recruiting
  Aplastic Anemia
  
• Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00220805 - Completed
  Macular Degeneration
  
• Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
  ClinicalTrials.gov Identifier: NCT00306033 - Completed
  Myasthenia Gravis
  
• Open Label, 48 Week Study of the Ability of Lopinavir/Ritonavir to Influence the Immune Response in Patients Who Are on an HIV Suppressive Regimen But Have Demonstrated a Blunted Immune Recovery.
  ClinicalTrials.gov Identifier: NCT00344487 - Recruiting
  HIV
  
• Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00093587 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003398 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003396 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Influence of Persistent CMV-Infection on Immune Senescence
  ClinicalTrials.gov Identifier: NCT00461695 - Recruiting
  Immune Senescence
  
• Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004145 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00005641 - Active, not recruiting
  Leukemia; Multiple Myeloma
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003270 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Safety and Immune Response to a Multi-Component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
  ClinicalTrials.gov Identifier: NCT00423254 - Recruiting
  Advanced Cancer
  
• Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00055185 - Active, not recruiting
  HIV Infections; Acquired Immune Deficiency Syndrome
  
• AMG 531 Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00415532 - Active, not recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
  
• Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00076570 - Active, not recruiting
  Kidney Transplantation
  
• Study of Alemtuzumab Versus Anti-Thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation
  ClinicalTrials.gov Identifier: NCT00331162 - Recruiting
  Graft Rejection
  
• Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00054236 - Recruiting
  adult acute erythroid leukemia; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Aplastic Anemia or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003816 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Fludarabine, Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00335608 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant
  ClinicalTrials.gov Identifier: NCT00354419 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
  ClinicalTrials.gov Identifier: NCT00220766 - Completed
  Immunologic Deficiency Syndrome; Agammaglobulinemia; Severe Combined Immunodeficiency; Wiskott-Aldrich Syndrome; Common Variable Immunodeficiency
  
• Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  ClinicalTrials.gov Identifier: NCT00220740 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00005852 - Active, not recruiting
  Lymphoma; Multiple Myeloma; Leukemia
  
• A Study to Evaluate the Effect of Thymoglobulin Induction Therapy and Reduced Doses of Calcineurin Inhibitors On the Incidence of Liver Transplant Rejection
  ClinicalTrials.gov Identifier: NCT00117689 - Active, not recruiting
  Liver Diseases; Transplant Rejection
  
• Yoga, Immune Function, and Health
  ClinicalTrials.gov Identifier: NCT00371397 - Recruiting
  Immune Function
  
• Filgrastim-Mobilized Peripheral Stem Cell Transplantation Compared With Bone Marrow Transplantation From Unrelated Donors in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00075816 - Recruiting
  acute leukemia; chronic leukemia; chronic myeloproliferative disorders; myelodysplastic and myeloproliferative disease
  
• Open Label Phase 3 Study of NABI-IGIV 10% [(HUMAN)] In Subjects With Primary Immune Deficiency Disorders (PIDD)
  ClinicalTrials.gov Identifier: NCT00538915 - Recruiting
  Primary Immune Deficiency Disorders; Antibody Deficiency Syndromes
  
• Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00317798 - Recruiting
  Drug Toxicity; Multiple Myeloma and Plasma Cell Neoplasm
  
• Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00488436 - Recruiting
  Myelodysplastic Syndrome
  
• Comparing Therapies for the Treatment of Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00001626 - Active, not recruiting
  Aplastic Anemia; Hematologic Disease
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00190502 - Recruiting
  Diabetes Mellitus, Type 1
  
• Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
  ClinicalTrials.gov Identifier: NCT00090194 - Completed
  Kidney Failure, Chronic
  
• A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00000827 - Completed
  HIV Infections
  
• Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00448201 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)
  ClinicalTrials.gov Identifier: NCT00405184 - Recruiting
  Primary Immune Deficiency (PID)
  
• Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00466843 - Recruiting
  Myelodysplastic Syndrome
  
• Influence of Corn Farming on the Immune System
  ClinicalTrials.gov Identifier: NCT00342121 - Active, not recruiting
  Cancer Risk
  
• Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003838 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; ...